For this, we took advantage of the Parkinson’s Disease-related protein Parkin, which stimulates the formation of lysosome-targeted MDVs and, importantly, inhibits the Snx9-dependent pathway in the context of antigen presentation29. The gene discussed is PRKN; the disease is Parkinson disease.